• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AMPA 谷氨酸受体剪接可变结构域缺失突变体中激动剂和配体活性的破坏。

Disruption of agonist and ligand activity in an AMPA glutamate receptor splice-variable domain deletion mutant.

作者信息

Johnson Wayne D, Parandaman Vijaya, Onaivi Emmanuel S, Taylor Robert E, Akinshola B Emmanuel

机构信息

Department of Pharmacology, Howard University College of Medicine, 520 W Street N.W., Washington, DC 20059, USA.

出版信息

Brain Res. 2008 Jul 30;1222:18-30. doi: 10.1016/j.brainres.2008.05.035. Epub 2008 May 23.

DOI:10.1016/j.brainres.2008.05.035
PMID:18585685
Abstract

The mechanisms by which agonists and other ligands bind ligand-gated ion channels are important determinants of function in neurotransmitter receptors. The partial agonist, kainic acid (KA) activates a less desensitized, and more robust AMPA receptor (AMPAR) current than full agonists, glutamate or AMPA. Cyclothiazide (CTZ), the allosteric modulator of AMPARs, potentiates receptor currents by inhibiting receptor desensitization resulting from agonist activation. We have constructed an AMPAR GluR1 subunit deletion mutant GluR1L3T(Delta739-784) by deleting the splice-variable "flip/flop" region of the L3 domain in the wild-type receptor and compared its function to that of the wild-type GluR1 receptor and an AMPAR substitution mutant GluR1A782N. When compared to GluR1, the potency of glutamate activation of GluR1L3T was increased, in contrast to a decrease in potency of activation and reduced sensitivity to optimal concentrations of KA. Furthermore, GluR1L3T was totally insensitive to CTZ potentiation of KA and glutamate-activated currents in Xenopus laevis oocytes. The potency of glutamate and KA activation of GluR1A782N was not significantly different from that of the wild-type GluR1 receptor although the mutant receptor currents were more sensitive to CTZ potentiation than the wild-type receptor current. This result is an indication that glutamate and KA binding to the agonist (S1/S2) domain on AMPAR can be modulated by an expendable splice-variable region of the receptor. Moreover, the effect of the allosteric modulator, CTZ on agonist activation of AMPAR can also be modified by a non-conserved amino acid residue substitution within the splice-variable "flip/flop" region.

摘要

激动剂和其他配体与配体门控离子通道结合的机制是神经递质受体功能的重要决定因素。部分激动剂 kainic 酸(KA)比完全激动剂谷氨酸或 AMPA 激活的脱敏程度更低、更强劲的 AMPA 受体(AMPAR)电流。环噻嗪(CTZ)是 AMPAR 的变构调节剂,通过抑制激动剂激活导致的受体脱敏来增强受体电流。我们通过删除野生型受体 L3 结构域的可变剪接“翻转/摆动”区域构建了一个 AMPAR GluR1 亚基缺失突变体 GluR1L3T(Delta739 - 784),并将其功能与野生型 GluR1 受体和 AMPAR 替代突变体 GluR1A782N 的功能进行了比较。与 GluR1 相比,GluR1L3T 的谷氨酸激活效力增加,而激活效力降低以及对最佳浓度 KA 的敏感性降低则相反。此外,在非洲爪蟾卵母细胞中,GluR1L3T 对 KA 和谷氨酸激活电流的 CTZ 增强作用完全不敏感。尽管突变体受体电流比野生型受体电流对 CTZ 增强作用更敏感,但 GluR1A782N 的谷氨酸和 KA 激活效力与野生型 GluR1 受体的效力没有显著差异。这一结果表明,谷氨酸和 KA 与 AMPAR 上激动剂(S1/S2)结构域的结合可被受体的一个可缺失可变剪接区域调节。此外,变构调节剂 CTZ 对 AMPAR 激动剂激活的作用也可通过可变剪接“翻转/摆动”区域内的一个非保守氨基酸残基替代来改变。

相似文献

1
Disruption of agonist and ligand activity in an AMPA glutamate receptor splice-variable domain deletion mutant.AMPA 谷氨酸受体剪接可变结构域缺失突变体中激动剂和配体活性的破坏。
Brain Res. 2008 Jul 30;1222:18-30. doi: 10.1016/j.brainres.2008.05.035. Epub 2008 May 23.
2
Heterogeneity and potentiation of AMPA type of glutamate receptors in rat cultured microglia.大鼠培养小胶质细胞中AMPA型谷氨酸受体的异质性与增强作用
Glia. 2004 Jul;47(1):68-77. doi: 10.1002/glia.20034.
3
Pharmacological characterization, localization, and regulation of ionotropic glutamate receptors in skate horizontal cells.鳐鱼水平细胞中离子型谷氨酸受体的药理学特性、定位及调节
Vis Neurosci. 2009 Jul-Aug;26(4):375-87. doi: 10.1017/S0952523809990149. Epub 2009 Aug 14.
4
Subtype-specific effects of lithium on glutamate receptor function.锂对谷氨酸受体功能的亚型特异性影响。
J Neurophysiol. 1999 Apr;81(4):1506-12. doi: 10.1152/jn.1999.81.4.1506.
5
Comparative analysis of the pharmacology of GluR1 in complex with transmembrane AMPA receptor regulatory proteins gamma2, gamma3, gamma4, and gamma8.与跨膜AMPA受体调节蛋白γ2、γ3、γ4和γ8结合的GluR1的药理学比较分析。
Neuroscience. 2009 Jan 12;158(1):78-88. doi: 10.1016/j.neuroscience.2007.12.047. Epub 2008 Jan 18.
6
Block of kainate receptor desensitization uncovers a key trafficking checkpoint.阻断海人酸受体脱敏揭示了一个关键的转运检查点。
Neuron. 2006 Dec 21;52(6):1037-46. doi: 10.1016/j.neuron.2006.12.006.
7
Pharmacological detection of AMPA receptor heterogeneity by use of two allosteric potentiators in rat hippocampal cultures.利用两种变构增强剂对大鼠海马培养物中AMPA受体异质性进行药理学检测。
Br J Pharmacol. 1998 Apr;123(7):1294-303. doi: 10.1038/sj.bjp.0701707.
8
Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling.通过定点诱变和分子建模确定的重组NR1/NR2A N-甲基-D-天冬氨酸受体中谷氨酸结合位点的结构特征。
Mol Pharmacol. 2005 May;67(5):1470-84. doi: 10.1124/mol.104.008185. Epub 2005 Feb 9.
9
Negative allosteric modulation of wild-type and mutant AMPA receptors by GYKI 53655.GYKI 53655对野生型和突变型AMPA受体的负变构调节作用
Mol Pharmacol. 1996 Jan;49(1):142-8.
10
Characterization of AMPA receptors on isolated amacrine-like cells in carp retina.鲤鱼视网膜中分离出的无长突细胞样细胞上AMPA受体的特性研究
Eur J Neurosci. 1999 Dec;11(12):4233-40. doi: 10.1046/j.1460-9568.1999.00851.x.